Search - Enter Keyword
 
Dangerous Drugs
Yaz-Yasmin-Ocella
Reglan
Avandia
Vioxx
Paxil
Bextra
Crestor
Fen Phen
Fosamax
Ephedra
Raptiva
Trasylol
Contraceptives
Digitek
Permax
Celebrex
Seroquel
Serzone
Accutane
Anti-Depressants
Fentanyl
Remicade
Strattera
Serevent
COX-2 Inhibitors
Defective Medical Devices
Shoulder Pain Pump
Guidant Defibrillators
Medtronic Sprint Fidelis Defibrillator Leads
Kugel Mesh Patch
Zimmer Durom Cup
Guidant Ancure Device
Toxic Substances
Welding Rods
Asbestos
Mesothelioma
Lead Poisoning
Medical Malpractice
Cerebral Palsy
Erb's Palsy
Birth Injury
Surgical Mistake
Cancer Misdiagnosis
Nursing Home Negligence
Hospital Negligence
Accidents
Car Accidents
Plane Accidents
Boat Accidents
Bus Accidents
Motorcycle Accidents
Toyota Sudden Unintended Acceleration
Toyota Prius Hybrid & Lexus HS 250h Hybrid Anti-lock Brake System
Toyota Corolla Steering Problem
Brain Injury
Spinal Cord Injury
Yamaha Rhino Rollover Injury
Dodge Truck and SUV Recall
Other Injuries
Slip and Fall
Insurance Bad Faith
Dog Bite Injury
Inadequate Security
Recall Forum
Consumer Products
Sexual Abuse
Product Liability
General Inquiries

Celebrex

Find out if you have a Celebrex® lawsuit

A settlement with Pfizer, the manufacturer of Celebrex and Bextra, and our Celebrex and Bextra clients has been reached.  As a result, we are no longer accepting new Celebrex or Bextra claims.

Concerns for cardiovascular related Celebrex® side effects have been raised in the media again following new reports on the dangers of the Cox-2 Inhibitor family of drugs. On February 16, 2005, the FDA's panel to evaluate the safety of these drugs featured testimony from Merck & Co. who told FDA advisers that research linking its withdrawn Vioxx to heart attacks and strokes may apply to the entire class of painkillers, including Celebrex® and Bextra®. This follows earlier news that Pfizer halted a Celebrex® cancer study due to the cardiovascular side effects experienced by study participants.

According to statements made by CNN on December 17, 2004, Pfizer CEO Hank McKinnell cited new results from clinical trials that he called "unexpected," and said the company was taking "immediate steps to fully understand the results and rapidly communicate new information to regulators, physicians and patients around the world." To read more of the story...

Like the recently recalled Merck arthritis drug Vioxx®, Celebrex® is a member of the COX-2 inhibitor family.

Celebrex® (celecoxib) was approved by the FDA on December 29, 1999. The drug is made by Pfizer for the treatment of pain and tenderness associated with osteoarthritis and adult rheumatoid arthritis. Celebrex has been prescribed to 27 million Americans and is the world's most widely prescribed arthritis drug, according to Pfizer.

If you suspect that Celebrex® has caused side effects or injured you, you should call our lawyers now at 1-800-THE-EAGLE (1-800-843-3245) or SUBMIT A SHORT AND SIMPLE CASE FORM HERE.

Links:
Vioxx Recall Information
Bextra Side Effects
Celebrex FDA Information
COX-2 Inhibitors
More Information:
Celebrex Articles
Celebrex Side Effects